United Kingdom radiation oncology 1 conference (UKRO 1): Accuracy and uncertainty in radiotherapy

British Journal of Radiology

Volumn 75, Issue 892, 2002, Pages 297-306

  Jones, B ^a   Aird, E ^b   Colyer, H ^c   Dobbs, J ^d   Harris, R ^e   Hoskin, P ^b   Mckenzie, A ^f   West, C ^g  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b MOUNT VERNON CANCER CENTRE   (United Kingdom)

^c UNIVERSITY OF KENT   (United Kingdom)

^d ST THOMAS HOSPITAL   (United Kingdom)

^e Plymouth Oncology Centre   (United Kingdom)

^f BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE   (United Kingdom)

^g CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL;

ACCURACY; BLADDER CANCER; CANCER; CANCER RADIOTHERAPY; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER SIMULATION; CONFERENCE PAPER; DIAGNOSTIC IMAGING; DRUG EFFICACY; HEALTH CARE DELIVERY; HEALTH SERVICES RESEARCH; HUMAN; LINEAR SYSTEM; MATHEMATICAL MODEL; MEDICAL AUDIT; MEDICAL DECISION MAKING; MEDICAL EDUCATION; MEDICAL PROFESSION; META ANALYSIS; MORBIDITY; NATIONAL HEALTH SERVICE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PERSONNEL MANAGEMENT; PHYSICS; PRACTICE GUIDELINE; QUALITY CONTROL; RADIATION DOSE; RADIOBIOLOGY; RADIOCHEMISTRY; RECTUM CANCER; RESOURCE ALLOCATION; RISK MANAGEMENT; STATISTICS; SYMPOSIUM; TREATMENT PLANNING; TUMOR; UNITED KINGDOM; UTERINE CERVIX CANCER; WORKLOAD;

EID: 0036555328     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.75.892.750297     Document Type: Conference Paper

References (50)

1. Clin Oncol 2001;13(Suppl. 2):S1-S15.
2. Mijnheer BJ, Battermann JJ, Wambersie A. What degree of accuracy is required and can be achieved in photon and neutron therapy? Radiother Oncol 1987;8:237-52.
3. Goitein M. Calculation of the uncertainty in the dose delivered during radiation therapy. Med Phys 1985;12:608-12.
4. Meijer GJ, Minken AW, van Ingen KM, Smulders B, Uiterwaal H, Mijnheer BJ. Accurate in vivo dosimetery of a randomised trial of prostate cancer irradiation. Int J Radiat Oncol Biol Phys 2001;49:1409-18.
5. McKenzie AL. How should breathing motion be combined with other errors when drawing margins around clinical target volumes? Br J Radiol 2000;73:973-7.
6. Bergstrom P, Lofroth PO, Widmark A. High precision conformal radiotherapy (HPCRT) of prostate cancer - a new technique for exact positioning of the prostate at the time of treatment. Int J Radiat Oncol Biol Phys 1998;42:305-11.
7. The BS, Mai WY, Augspurger ME, Uhl BM, McGary J, Dong L, et al. Intensity modulated radiation therapy (IMRT) following prostatectomy: more favourable acute genitourinary toxicity profile compared to primary IMRT for prostate cancer. Int J Radiat Oncol Biol Phys 2001;49:465-72.
8. Seddon B, Bidmead M, Wilson J, Khoo V, Dearnaley D. Target volume definition in conformal radiotherapy for prostate cancer: quality assurance in the MRC RT-01 trial. Radiother Oncol 2000;56:73-83.
9. van Dieren EB, Nowak PJ, Wijers OB, van Sornsen deKoste JR, van der Est H, Binnekamp DP, et al. Beam intensity modulation using tissue compensators or dynamic multileaf collimation in three-dimensional conformal radiotherapy of primary cancers of the oropharynx and larynx, including the elective neck. Int J Radiat Oncol Biol Phys 2000;47:1299-309.
10. Wijers OB, Levendag PC, Tan T, van Dieren EB, van Sornsen deKoste JR, van der Est H, et al. A simplified CT-based target definition for elective irradiation of the neck. Radiother Oncol 1999;52:35-42.
11. Zelefsky M, Fuks Z, Happersett L, et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 2000;55:241-9.
12. Sharpe M, Miller B, Yan D, Wong J. Monitor unit settings for intensity modulated beams delivered using a step-and-shoot approach. Med Phys 2000;27:2719-25.
13. Evans P, Donovan E, Partridge M, et al. The delivery of intensity modulated radiotherapy to the breast using multiple static fields. Radiother Oncol 2000;57:79-89.
14. Nutting C, Khoo V, Walker V, et al. A randomised study of the use of a customised immobilisation system in the treatment of prostate cancer with conformal radiotherapy. Radiother Oncol 2000;54:1-9.
15. Yan D, Ziaja E, Jaffray D, Wong J, Brabbins D, Vicini F, et al. The use of adaptive radiation therapy to reduce set up error: a prospective clinical study. Int J Radiat Oncol Biol Phys 1998;41:715-20.
16. Yan D, Lockman D, Brabbins D, Tyburski L, Martinez A. An off line strategy for constructing a patient specific planning target volume in adaptive treatment process for prostate cancer. Int J Radiat Oncol Biol Phys 2000;48:289-302.
17. Drzymala RE, Mohan R, Brewster L, Chu J, Goitein M, Harms W, et al. Dose-volume histograms. Int J Radiat Oncol Biol Phys 1991;21:71-8.
18. Lawrence TS, Kessler ML, Ten Haken RK. Clinical interpretation of dose-volume histograms: the basis for normal tissue preservation and tumor dose escalation. Front Radiat Ther Oncol 1996;29:57-66.
19. Millwater CJ, MacLeod AS, Thwaites DI. In vivo semiconductor dosimetry as part of routine quality assurance. Br J Radiol 1998;71:661-8.
20. Redpath A, Thwaites D, Rodger A, et al. A multidisciplinary approach to improving the quality of tangential chest wall and breast irradiation for carcinoma of the breast. Radiother Oncol 1992;23:118-26.
21. Craig T, Battista J, Moiseenko V, et al. Consideration for the implementation of target volume protocols in radiation therapy. Int J Radiat Oncol Biol Phys 2001;49:241-50.
22. McKenzie A, van Herk M, Mijnheer B. The width margins in radiotherapy treatment plans. Phys Med Biol 2000;45:3331-42.
23. Fenwick J, Khoo V, Nahum A, et al. Correlations between dose-surface histograms and the incidence of long term rectal bleeding following conformal or conventional radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys 2001;49:473-80.
24. Conway J, Robinson M. CT virtual simulation. Br J Radiol 1997;70:S106-S118.
25. de Boer H, van Sornsen de Koste J, Senan S, et al. Analysis and reduction of 3D systematic and random errors during the simulation and treatment of lung cancer with CT-based external beam radiotherapy dose planning. Int J Radiat Oncol Biol Phys 2001;49:857-68.
26. Valicenti R, Waterman F, Corn B, et al. A prospective, randomised study addressing the need for physical simulation following virtual simulation. Int J Radiat Oncol Biol Phys 1997;39:1131-5.
27. Stryker J, Shafer J, Beatty R. Assessment of accuracy of daily set-ups in prostate radiotherapy using electronic imaging. Br J Radiol 1999;72:579-83.
28. Mubata C, Bidmead A, Ellingham L, et al. Portal imaging protocol for radical dose-escalated radiotherapy treatment of prostate cancer. Int J Radiat Oncol Biol Phys 1998;40:221-31.
29. James H, Atherton S, Budgell G, et al. Verification of dynamic multileaf collimation using an electronic portal imaging device. Phys Med Biol 2000:45:495-509.
30. Bel A, Bartelink H, Vijlbrief R, et al. Transfer errors of planning CT to simulator: a possible source of set-up inaccuracies? Radiother Oncol 1994;31:176-80.
31. Griffiths S, Short C. Radiotherapy: principles to practice. Chapters 25 and 26. London: Churchill Livingston, 1994;277-89.
32. Sur RK, Clinkard J, Jones WG, et al. Changes in target volume during radiotherapy treatment of invasive bladder carcinoma. Clin Oncol 1993;5:30-3.
33. Dobson M, Carrington B, Collins C, et al. The assessment of irradiated bladder carcinoma using dynamic contrast-enhanced MR imaging. Clin Radiol 2001;56:94-8.
34. Ling CC, Humm J, Larson S, Amols H, Fuks Z, Leibel S, et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 2000;47:551-60.
35. Munley MT, Marks LB, Hardenberg PH, Bentel G.C. Functional imaging of normal tissues with nuclear medicine: applications in radiotherapy. Semin Radiat Oncol 2001;11:28-36.
36. Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA Jr, Al-Sarraf M, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999;281:1623-7.
37. Wong R, Malthaner R. Esophageal cancer: a systematic review. Curr Probl Cancer 2000;24:293-376.
38. Nilsson S, Ragnhammar P, Glimelius B, Nygren P, SBU-group. Swedish Council of Technology Assessment in Health Care. A systematic overview of chemotherapy effects in urothelial bladder cancer. Acta Oncol 2001;40:371-90.
39. Hall EJ, Schiff PB, Hanks GE, Brenner DJ, Russo J, Chen J, et al. A preliminary report: frequency of A-T heterozygotes among prostate cancer patients with severe late responses to radiation therapy. Cancer J Sci Am 1998;4:385-9.
40. Munster PN, Srethapadki M, Moasser MM, Rosen N. Inhibition of heat shock protein 90 function by ansamycins causes the morphological and functional differentiation of breast cancer cells. Cancer Res 2001;61:2945-52.
41. Yang J, Yang JM, Iannone M, Shih WJ, Lin Y, Hait WN. Disruption of the EF-2 kinase/Hsp90 protein complex: a possible mechanism to inhibit glioblastoma by geldanamycin. Cancer Res 2001;61:4010-6.
42. Denton AS, Bond SJ, Matthews S, Bentzen SM, Maher EJ. National audit of the management and outcome of carcinoma of the cervix treated with radiotherapy in 1993. Clin Oncol 2000;12:347-53.
43. Rubin P, Constine LS, Fajardo LF, Phillips TL, Wasserman TH. EORTC Late Effects Working Group. Overview of late effects normal tissues (LENT) scoring system. Radiother Oncol 1995;35:9-10.
44. Jones B, Dale RG, Deehan C, Hopkins KI, Morgan DAL. The role of biologically effective dose (BED) in clinical oncology. Clin Oncol 2001;13:71-81.
45. Jones B, Dale RG. Radiobiological modelling and clinical trials. Int J Radiat Oncol Biol Phys 2000;48-259-65.
46. Dale RG, Hendry JH, Jones B, Deehan C, Roberton G. The correction of unintended treatment interruptions during radiotherapy. Clin Oncol 2002 (in press).
47. 2, CFE) in a tumor control probability model increases their prognostic significance: a study in cervical carcinoma treated with radiation therapy. Int J Radiat Oncol Biol Phys 2001;50:1113-22.
48. Cooper RA, Carrington B, Loncaster JM, Davidson SE, Todd SM, Logue FP, et al. Tumour oxygenation levels correlate with dynamic contrast-enhanced MRI parameters in carcinoma of the cervix. Radiother Oncol 2000;57:53-9.
49. Priestman TJ, Bullimore JA, Godden TP, Deutsch GP. Related Articles The Royal College of Radiologists' Fractionation Survey. Clin Oncol (R Coll Radiol) 1989;1:39-46.
50. Shah N, Saunders MI, Dische S. A pilot study of postoperative CHART and CHARTWEL in head and neck cancer. Clin Oncol (R Coll Radiol) 2000;12:392-6.